Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 33.10 is 50% above its 1-year average of 22.06, near the high end of its 1-year range (11.03–33.10).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly quick ratio; no daily interpolation.
Limited quarterly history available
Quick Ratio needs at least three reported quarters before a meaningful chart is shown.
QUICK RATIO (ACID-TEST)
33.10
QUICK RATIO (ACID-TEST) AVG TTM
N/A
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.07
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
+978.14%
vs the sector median at left
Avalyn Pharma Inc. Common Stock
Market Cap
$1.15B
Quick Ratio (Acid-Test)
33.10
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
Quick Ratio (Acid-Test)
1.38
TTM Avg
3.96
3Y Avg
6.78
5Y Avg
9.79
Market Cap
$1.14B
Quick Ratio (Acid-Test)
2.93
TTM Avg
3.33
3Y Avg
2.34
5Y Avg
2.11
Market Cap
$1.17B
Quick Ratio (Acid-Test)
10.42
TTM Avg
4.62
3Y Avg
5.77
5Y Avg
6.99
Market Cap
$1.17B
Quick Ratio (Acid-Test)
19.73
TTM Avg
13.53
3Y Avg
9.78
5Y Avg
15.63
Market Cap
$1.13B
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.54
3Y Avg
2.42
5Y Avg
2.25
Market Cap
$1.13B
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.01
3Y Avg
3.15
5Y Avg
3.64
Market Cap
$1.11B
Quick Ratio (Acid-Test)
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
Market Cap
$1.21B
Quick Ratio (Acid-Test)
1.05
TTM Avg
1.06
3Y Avg
1.16
5Y Avg
1.68
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.15B | 33.10 | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 1.38 | 3.96 | 6.78 | 9.79 |
| OPKO Health, Inc. (OPK)vs › | $1.14B | 2.93 | 3.33 | 2.34 | 2.11 |
| Nektar Therapeutics (NKTR)vs › | $1.17B | 10.42 | 4.62 | 5.77 | 6.99 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 19.73 | 13.53 | 9.78 | 15.63 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 1.71 | 2.54 | 2.42 | 2.25 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 2.08 | 2.01 | 3.15 | 3.64 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.11B | 11.59 | 21.25 | 14.51 | 14.51 |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 1.05 | 1.06 | 1.16 | 1.68 |
| MannKind Corporation (MNKD)vs › | $1.22B | 1.41 | 2.22 | 2.73 | 2.72 |
Quick Ratio
33.10
Excludes inventory
Current Ratio
33.10
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 33.10 |
| 2026-03-31 | 11.03 |
